Spyre Therapeutics (SYRE)
91.16
+0.21 (0.23%)
Upcoming Events
Latest Headlines
Baird Reiterates Outperform Rating on Spyre (SYRE)
September 9, 2026 5:40 AM - StreetInsider
Spyre's SPY003 meets primary endpoint in Phase 2 UC trial
September 8, 2026 8:04 AM - StreetInsider
Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations
September 8, 2026 8:00 AM - StreetInsider
Spyre Therapeutics to Participate in Upcoming September Investor Conferences
September 3, 2026 4:05 PM - StreetInsider
Spyre (SYRE) PT Lowered to $116 at Baird
August 27, 2026 6:19 AM - StreetInsider
Guggenheim Reiterates Buy Rating on Spyre (SYRE)
August 27, 2026 2:20 AM - StreetInsider
Spyre (SYRE) Reiterated at Buy by Stifel on Topline Results From RA PoC Sub-Study
August 26, 2026 7:28 AM - StreetInsider
After-Hours Movers: INTU, SMTC, SYRE, ZM, NCNO
August 25, 2026 4:41 PM - StreetInsider
Form 8-K Spyre Therapeutics, Inc. For: Aug 25
August 25, 2026 4:05 PM - SEC Filing
Spyre RA drug trial misses internal bar despite some efficacy
August 25, 2026 4:01 PM - StreetInsider
Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-study of the SKYWAY Phase 2 Trial of SPY072
August 25, 2026 4:01 PM - StreetInsider
Form SCHEDULE 13G/A Spyre Therapeutics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
August 14, 2026 5:24 PM - SEC Filing
Form SCHEDULE 13G/A Spyre Therapeutics, Inc. Filed by: RTW INVESTMENTS, LP
August 14, 2026 8:10 AM - SEC Filing
Spyre (SYRE) PT Raised to $140 at Jones Trading
August 12, 2026 9:45 AM - StreetInsider
Form 4 Spyre Therapeutics, Inc. For: Aug 07 Filed by: Albers Jeffrey W.
August 10, 2026 9:32 PM - SEC Filing
Spyre Therapeutics launches SPY772 program and Phase 2 trial in HS
August 10, 2026 8:00 AM - StreetInsider
Spyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa
August 10, 2026 8:00 AM - StreetInsider
Form 144 Spyre Therapeutics, Inc. Filed by: Albers Jeffrey W.
August 7, 2026 4:40 PM - SEC Filing
Form 144 Spyre Therapeutics, Inc. Filed by: Albers Jeffrey W.
August 7, 2026 4:40 PM - SEC Filing
Spyre Therapeutics Announces Grants of Inducement Awards
August 7, 2026 4:05 PM - Globe NewsWire
Form 4 Spyre Therapeutics, Inc. For: Aug 03 Filed by: Burrows Scott L
August 5, 2026 9:32 PM - SEC Filing
Form 4 Spyre Therapeutics, Inc. For: Aug 03 Filed by: Turtle Cameron
August 5, 2026 9:31 PM - SEC Filing
Spyre (SYRE) PT Raised to $115 at Wells Fargo
August 5, 2026 7:58 AM - StreetInsider
Spyre Therapeutics, Inc. (SYRE) Tops Q2 EPS by 40c
August 4, 2026 5:51 PM - StreetInsider
Form 8-K Spyre Therapeutics, Inc. For: Aug 04
August 4, 2026 4:06 PM - SEC Filing
Form 10-Q Spyre Therapeutics, Inc. For: Jun 30
August 4, 2026 4:03 PM - SEC Filing
Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 4, 2026 4:02 PM - StreetInsider
Form 144 Spyre Therapeutics, Inc. Filed by: Burrows Scott L
August 3, 2026 4:52 PM - SEC Filing
Wolfe Research Downgrades Spyre (SYRE) to Peerperform
July 28, 2026 5:34 AM - StreetInsider
Spyre (SYRE) PT Raised to $120 at Mizuho
July 13, 2026 6:44 AM - StreetInsider
Form 4 Spyre Therapeutics, Inc. For: Jul 01 Filed by: Burrows Scott L
July 2, 2026 9:34 PM - SEC Filing
Form 4 Spyre Therapeutics, Inc. For: Jul 01 Filed by: Sloan Sheldon
July 2, 2026 9:33 PM - SEC Filing
Form 4 Spyre Therapeutics, Inc. For: Jul 01 Filed by: Turtle Cameron
July 2, 2026 9:32 PM - SEC Filing
Spyre Therapeutics Announces Grants of Inducement Awards
July 2, 2026 4:05 PM - Globe NewsWire
Form 144 Spyre Therapeutics, Inc. Filed by: Turtle Cameron
July 1, 2026 5:02 PM - SEC Filing
Form 4 Spyre Therapeutics, Inc. For: Jun 25 Filed by: Burrows Scott L
June 26, 2026 9:32 PM - SEC Filing
Spyre Therapeutics (SYRE) files mixed shelf
June 26, 2026 4:09 PM - StreetInsider
Form S-3ASR Spyre Therapeutics, Inc.
June 26, 2026 4:06 PM - SEC Filing
Form 144 Spyre Therapeutics, Inc. Filed by: Burrows Scott L
June 25, 2026 4:03 PM - SEC Filing
Form 144 Spyre Therapeutics, Inc. Filed by: Fairmount Funds Management LLC
June 23, 2026 9:58 PM - SEC Filing
Form 4 Spyre Therapeutics, Inc. For: Jun 23 Filed by: Fairmount Healthcare Fund II L.P.
June 23, 2026 9:56 PM - SEC Filing
Form SCHEDULE 13D/A Spyre Therapeutics, Inc. Filed by: Fairmount Funds Management LLC
June 23, 2026 9:45 PM - SEC Filing
Form 4 Spyre Therapeutics, Inc. For: Jun 22 Filed by: HENDERSON MICHAEL THOMAS
June 23, 2026 9:33 PM - SEC Filing
Spyre (SYRE) PT Raised to $135 at Deutsche Bank
June 23, 2026 7:18 AM - StreetInsider
Form 144 Spyre Therapeutics, Inc. Filed by: HENDERSON MICHAEL THOMAS
June 22, 2026 4:45 PM - SEC Filing
Guggenheim says buy this biotech stock
June 18, 2026 4:00 PM - StreetInsider
Full Article List
